Paciocco Giuseppe, Uslenghi Elisabetta, Bianchi Achille, Mazzarella Gennaro, Roviaro Giancarlo C, Vecchi Giuseppe, Harari Sergio
Department of Cardio-Thoracic and Respiratory Science, Second University of Naples, Naples, Italy.
Chest. 2004 Jan;125(1):135-42. doi: 10.1378/chest.125.1.135.
High-resolution CT (HRCT) scanning plays an important role in the diagnosis of diffuse cystic lung diseases (DCLDs). However, its role in the clinical evaluation of patients affected by DCLD has not yet been well-clarified. At present, pulmonary function tests are the only methods available for the evaluation of lung impairment due to these diseases, but their sensitivity and reliability are still limited.
The aim of this study was to correlate the quantitative score of cystic-aerial lesions obtained by a HRCT density mask (DM) software with pulmonary function data in DCLDs.
Spirometry, lung volumes, diffusion capacity, arterial blood gas (ABG) analysis, 6-min walking test (6-MWT), and HRCT with DM quantitative evaluation were performed in a cohort of 25 patients (lymphangioleiomyomatosis [LAM], 13 patients; Langerhans cells histiocytosis [LCH], 12 patients). Linear regression was used for the statistical analysis. The sum and mean of the air-trapping percentages at three different levels of DM study (ie, aortic arch, left lower lobe bronchus origin, and 2 cm from the diaphragmatic muscle), and various functional parameters and exercise performance values were matched for the analysis.
An obstructive pattern was present in 13 patients (52%; LCH group, 8 patients; LAM group, 5 patients). A predominant restrictive pattern was detected only in three patients (12%; LCH group, two patients; LAM group, one patient). Nine patients (36%) walked < 350 m, and 14 of 23 patients (61%) had a significant decrease in arterial oxygen saturation during exercise (> 4 U). The results of DM quantitative study (sum and mean) significantly correlated with FVC (r = - 0.56; p < 0.001), FEV(1)/vital capacity (r = - 0.94; p < 0.002), midexpiratory phase of forced expiratory flow (r = - 0.84; p < 0.05), FEV(1) (r = - 0.82; p < 0.05), and diffusing capacity of the lung for carbon monoxide (r = - 0.82; p < 0.05), bronchial airway resistance (r = 0.79; p < 0.05), and distance walked on the 6-MWT (r = - 0.53; p < 0.05). No significant correlation was found with the results of ABG analysis.
In DCLDs, HRCT scans with quantitative assessment performed by a DM software showed a very good correlation with functional parameters. Therefore, DM could be considered, in combination with a complete functional assessment, in the initial evaluation of patients affected by DCLDs. However, further studies are needed to assess its usefulness in the follow-up of these patients.
高分辨率CT(HRCT)扫描在弥漫性囊性肺疾病(DCLD)的诊断中起着重要作用。然而,其在DCLD患者临床评估中的作用尚未得到充分阐明。目前,肺功能测试是评估这些疾病所致肺损伤的唯一可用方法,但其敏感性和可靠性仍然有限。
本研究旨在将通过HRCT密度掩膜(DM)软件获得的囊性气腔病变定量评分与DCLD患者的肺功能数据相关联。
对25例患者(淋巴管平滑肌瘤病[LAM],13例;朗格汉斯细胞组织细胞增多症[LCH],12例)进行了肺活量测定、肺容积、弥散功能、动脉血气(ABG)分析、6分钟步行试验(6-MWT)以及带有DM定量评估的HRCT检查。采用线性回归进行统计分析。将DM研究三个不同层面(即主动脉弓、左下叶支气管起始处和距膈肌2 cm处)的气体潴留百分比总和及平均值与各种功能参数和运动表现值进行匹配分析。
13例患者(52%)呈现阻塞性模式(LCH组8例,LAM组5例)。仅3例患者(12%)检测到以限制性为主的模式(LCH组2例,LAM组1例)。9例患者(36%)步行距离<350 m,23例患者中有14例(61%)在运动期间动脉血氧饱和度显著下降(>4 U)。DM定量研究结果(总和及平均值)与用力肺活量(FVC)(r = -0.56;p <0.001)、第1秒用力呼气容积/肺活量(FEV(1)/VC)(r = -0.94;p <0.002)、用力呼气流量中期(r = -0.84;p <0.05)、FEV(1)(r = -0.82;p <0.05)、肺一氧化碳弥散量(r = -0.82;p <0.05)、支气管气道阻力(r = 0.79;p <0.05)以及6-MWT步行距离(r = -0.53;p <)显著相关。与ABG分析结果未发现显著相关性。
在DCLD中,采用DM软件进行定量评估的HRCT扫描显示与功能参数具有很好的相关性。因此,在对DCLD患者进行初始评估时,可将DM与全面的功能评估相结合考虑。然而,需要进一步研究评估其在这些患者随访中的实用性。